🔎 Trials Near Me

Nyumbani › Limfoma ya Eneo la Mpaka › Florida

Majaribio ya kliniki ya Limfoma ya Eneo la Mpaka katika jimbo la Florida

Masomo 15 ya Limfoma ya Eneo la Mpaka yanatafuta washiriki katika vituo vya jimbo la Florida.

Miji katika jimbo la Florida

Maandishi rasmi ya utafiti (Kiingereza)

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

  • Mayo Clinic Jacksonville, Jacksonville
  • Mount Sinai Medical Center Braman Comprehensive Cancer Center, Miami
  • Tampa General Hospital Cancer Institute, Tampa
InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 28 Sep 2026 · NCT05006716

Rituximab and Zanubrutinib in Patients With Indolent B-cell Lymphomas

  • Moffitt Cancer Center, Tampa
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 28 Sep 2026 · NCT06350318

Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma

  • UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables
  • UM Sylvester Comprehensive Cancer Center at Coral Springs, Coral Springs
  • UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach
  • na zaidi ya 7
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 24 Sep 2026 · NCT04840602

Open-label of Loncastuximab Tesirine (ADCT-402) in Relapsed/Refractory Marginal Zone Lymphoma

  • University of Miami, Miami
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 21 Sep 2026 · NCT05296070

A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma

  • Boca Raton Clinical Research (BRCR) Global, Plantation
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 14 Ago 2026 · NCT06149286

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

  • Mayo Clinic, Clinical Trials Referral Office, Jacksonville
InaajiriHatua 1/2
Umri 13 hadi 90 · Jinsia zote · Imesasishwa 6 Ago 2026 · NCT06533579

A Study of APG-3288 in Relapsed/Refractory Blood Cancers

  • Mayo Clinic, Jacksonville
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 30 Jul 2026 · NCT07424833

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

  • University of Miami, Miami
  • Florida Cancer Specialists, Sarasota
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 2 Jul 2026 · NCT05131022

Integrated Molecular and Clinical Profiling to Improve Disease Characterization and Outcome Prediction in Nodal Marginal Zone Lymphoma

  • University of Miami, Miami
InaajiriUtafiti wa uchunguzi
Umri 18 na zaidi · Jinsia zote · Imesasishwa 22 Jun 2026 · NCT05700149

Study of SGR-1505 in Mature B-Cell Neoplasms

  • Napa Research, Pompano Beach
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 13 Feb 2026 · NCT05544019

AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma

  • Mount Sinai Comprehensive Cancer Center, Miami Beach
  • Moffitt Cancer Center, Tampa
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 10 Des 2025 · NCT05602363

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Jacksonville
  • Massive Bio SYNERGY-AI site, Miami
  • Massive Bio SYNERGY-AI site, Tampa
InaajiriUtafiti wa uchunguzi
Umri wote · Jinsia zote · Imesasishwa 28 Okt 2025 · NCT03452774

Epcoritamab in Patients With Newly Diagnosed Marginal Zone Lymphoma (MZL)

  • University of Miami, Miami
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 28 Okt 2025 · NCT06796998

A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies

  • Florida Cancer Specialists, Sarasota
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 2 Okt 2025 · NCT05780034

Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.